Speaking of looking forward I really feel that the market had priced SGH for success. Yet another year of negative results, albeit better than last year, might be the final straw.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025